Mobile Application Intervention

BEHAVIORAL4 trials

Sponsors

Massachusetts General Hospital, Janssen Scientific Affairs, LLC, Baskent University, University of Michigan

Conditions

Adherence to Medication RegimeAtrial FibrillationCancerHeart FailureSymptom Management

Phase 4

Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation

CompletedNCT02996435

Janssen Scientific Affairs, LLCAtrial Fibrillation

Start: 2016-12-21End: 2018-03-22Updated: 2018-10-26

Unknown Phase

Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer

CompletedNCT02157519

Massachusetts General HospitalAdherence to Medication Regime, Cancer

Start: 2015-02-18End: 2016-12-31Updated: 2018-11-19

Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management

CompletedNCT04626830

Baskent UniversityAdherence to Medication Regime, Cancer, Symptom Management

Start: 2018-06-25End: 2019-12-01Updated: 2020-11-13

Mobile Health Intervention to Increase Activity in Heart Failure Study

Not yet recruitingNCT07750262

University of MichiganHeart Failure

Start: 2026-08-01End: 2027-11-01Target: 50Updated: 2026-08-06

Related Papers

The effect of a mobile application on treatment adherence and symptom management in patients using oral anticancer agents: A randomized controlled trial.

2021-05-0414 citations

Randomized trial of a smartphone mobile app for adherence to oral chemotherapy.

Journal of Clinical Oncology2017-11-012 citations

Patient engagement with a smartphone mobile app for adherence to oral chemotherapy.

Journal of Clinical Oncology2017-11-011 citations

Randomized trial of a smartphone mobile app for adherence to oral chemotherapy.

Journal of Clinical Oncology2017-05-206 citations

Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and Development

JMIR Research Protocols2017-04-2094 citations

Development of a mobile application (app) for improving symptoms and adherence to oral chemotherapy in patients with cancer.

Journal of Clinical Oncology2015-10-101 citations